In the mountain town of Piñas, Ecuador, many residents possess a genetic condition known as Laron syndrome. This rare disorder hinders the body’s ability to utilize growth hormones, typically resulting in a height under 1.2 meters. For twin sisters María Luisa and María del Cisne, who have the syndrome, leaning on each other has been vital for navigating daily challenges.
Researchers suggest this condition might offer unexpected health benefits. Studies indicate that individuals with Laron syndrome exhibit significantly lower rates of diabetes and cancer compared to the general population. Dr. Jaime Guevara, an endocrinologist who has studied this community for decades, is working with experts like Dr. Valter Longo to understand if these protective biological mechanisms can be replicated through medicine or diet to help others.
The mutation, originally identified by Professor Zvi Laron sixty years ago, is linked to a defect in the liver’s growth hormone receptor, which prevents the production of Insulin-like Growth Factor 1 (IGF-1). Scientists believe lower levels of IGF-1 might help the body avoid diseases by allowing cancer cells to die off. However, the discovery is not a perfect shield; for example, María del Cisne was diagnosed with colon cancer two years ago, serving as a reminder that these individuals are not entirely immune.
Access to modern treatments, such as the drug Increlex, remains a significant hurdle. The medication can assist children with growth spurts, yet it is prohibitively expensive and difficult to secure for families like that of two-year-old Camila. While the twins missed the opportunity for such treatment in their youth, they and the medical community remain hopeful that studying their unique genetic profile will eventually contribute to meaningful scientific breakthroughs for the global population.